Trypanosoma cruzi: Inhibition of α-hydroxyacid dehydrogenase isozyme II by N-allyl and N-propyl oxamates and their effects on intact epimastigotes

Memorias do Instituto Oswaldo Cruz

Volumn 99, Issue 8, 2004, Pages 831-837

  Chena, Miguel A ^a,c,d   Elizondo Jiménez, Silvia ^a,c,d   Rodríguez Páez, Lorena ^a,b   Nogueda Torres, Benjamín ^a,b,c   Baeza Ramírez, Isabel ^a,b,c   Wong Ramírez, Carlos ^a,b,c  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b COFAA IPN ^*  (Mexico)

^c Jalisco   (Mexico)

^d PIFI 1PN ^*

Author keywords

Ethyl N allyl oxamate; Ethyl N propyl oxamate; N allyl oxamate; N propyl oxamate; Trypanosoma cruzi; Trypanosoma cruzi hydroxyacid dehydrogenase isozyme II inhibition; hydroxyacid dehydrogenase

Indexed keywords

2 HYDROXYACID DEHYDROGENASE; ANTITRYPANOSOMAL AGENT; BENZNIDAZOLE; ENZYME INHIBITOR; ESTER DERIVATIVE; ETHYL N ALLYLOXAMATE; ETHYL N PROPYLOXAMATE; ISOENZYME; N ALLYLOXAMATE; N PROPYLOXAMATE; NIFURTIMOX; NITROGEN; OXAMIC ACID; OXIDOREDUCTASE; UNCLASSIFIED DRUG;

ANTIPROTOZOAL ACTIVITY; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; ENERGY METABOLISM; ENZYME INHIBITION; EPIMASTIGOTE; KINETICS; NONHUMAN; PROTEIN FUNCTION; TRYPANOSOMA CRUZI;

TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 13844254062     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02762004000800009     Document Type: Article

References (35)

1. Aldunate J, Repetto Y, Letelier ME, Morello A 1987. The carboxylesterases of Trypanosoma cruzi epimastigotes. Comp Biochem Physiol B 86: 67-71.
2. Baker BR 1967. Design of Active-site Directed Irreversible Enzyme Inhibitors, John Wiley and Sons, New York.
3. Bakker BM, Westerhoff HV, Opperdoes FR, Michels PAM 2000. Metabolic control analysis of glycolysis in trypanosomes as an approach to improve selectivity and effectiveness of drugs. Mol Biochem Pharmacol 106: 1-10.
4. Blanco A, Aoqui A, Montamat E, Rovai L 1983. Effect of gossypol upon motility and ultrastructure of Trypanosoma cruzi. J Protozool 30: 643-651.
5. Blanco A, Burgos C, Gerez de Burgos NMC, Montamat EE 1976. Properties of the testicular lactate dehydrogenase isozyme. Biochem J 153: 165-172.
6. Brener Z 1962. Therapeutic activity and criterion of cure in mice experimentally infected with Trypanosoma cruzi. Rev Inst Med Trop São Paulo 4: 389-396.
7. Cannata JJ, Frasch AC, Cataldi de Flombaum MA, Segura AL, Cazzulo JJ 1979. Two forms of malic enzyme with different regulatory properties in Trypanosoma cruzi. Biochem J 184: 409-419.
8. Chiari E, Diaz J C, Lana M, Chiari C A 1989. Hemocultures for the parasitological diagnosis of human chronic Chagas' disease. Rev Soc Bras Med Trop 22: 19-23.
9. Coronel CE, Burgos C, Gerez de Burgos NMC, Rovai E, Blanco A 1983. Catalytic properties of the sperm specific lactate dehydrogenase (LDH-x or C4) from different species. J Exp Zool 225: 379-385.
10. Coronel CE, Gallina FG, Gerez de Burgos NM, Burgos C, Blanco A 1986. Properties of the branched-chain-2-hydroxyacid/ 2-oxoacid shuttle in mouse spermatozoa. Biochem J 235: 853-858.
11. Coronel C, Gerez de Burgos NM, Burgos C, Blanco A 1980. Separación y propiedades catalíticas de las isoenzimas de la α- hidroxiácido deshidrogenasa de Trypanosoma cruzi. Medicina (Buenos Aires) 40: 159-164.
12. Coronel CE, Rovai LE, Gerez de Burgos NM, Burgos C, Blanco A 1981. Properties of α-hydroxyacid dehydrogenase isozymes from Trypanosoma cruzi. Mol Biochem Parasitol 4: 29-38.
13. DerVartanian VDV, Zeylemaker WP 1969. Succinate dehydrogenase. Meth Enzymol 13: 81-90.
14. Deutsch J 1995. Glucose-6-phosphate dehydrogenase. Meth Enzym Analysis 3: 190-197.
15. Gerez de Burgos NMC, Blanco A, Paulone I, Segura EL 1976. Actividad de α-hidroxiácido deshidrogenasa en Trypanosoma cruzi. Acta Physiol Latinoam 26: 10-19.
16. Gerez de Burgos NM, Blanco A, Segura EL 1978. Formas moleculares de α-hidroxiácido deshidrogenasa en Trypanosoma cruzi. Medicina (Buenos Aires) 38: 151-154.
17. Gerez de Burgos NM, Burgos C, Montamat EE, Rovai LE, Blanco A 1984. Inhibition by gossypol of oxidoreductases from Trypanosoma cruzi. Biochem Pharmacol 33: 955-959.
18. Juan S, Segura EL, Cazzulo JJ 1978. Purification and some properties of the NADP-linked glutamate dehydrogenase from Trypanosoma cruzi. Int J Biochem 9: 95-400.
19. Lakhdar-Ghazal F, Blonski C, Willson M, Michels P, Perie J 2002. Glycolysis and proteases as targets for the design of new antitrypanosome drugs. Curr Top Med Chem 2: 439-456.
20. Michels PAM 1988. Compartimentation of glycolysis in trypanosomes: a potential target for new trypanocidal drugs. Biol Cell 64: 157-164.
21. Montamat EE, Arauzo SS, Blanco A 1987. Subcellular localization of leucin amino transferase and α-hydroxyacid dehydrogenase in Trypanosoma cruzi. Mol Biochem Parasitol 22: 185-193.
22. Montamat EE, Burgos C, Gerez de Burgos NM 1982. Inhibitory action of gossypol on enzymes and growth of Trypanosoma cruzi. Science 218: 288-289.
23. Montamat EE, Vermouth NT, Blanco A 1988. Subcellular localization of branched-chain aminoacid amino transferase and lactate dehydrogenase C4 in rat and mouse spermatozoa. Biochem J 255: 1053-1056.
24. Nogueda TB, Rodríguez-Páez L, Baeza I, Wong C 2001. Trypanocidal activity of 4-isopropyl salicylaldehyde and 4-isopropyl salicylic acid on Trypanosoma cruzi. Rev Latamer Microbiol 43: 1-6.
25. Opperdoes FR, Michels PA 2001. Enzymes of carbohydrate metabolism as potential drug targets. Int J Parasitol 31: 482-490.
26. Repetto Y, Aldunate J, Morello A 1983. Trypanosoma cruzi: carboxylesterase activity in intact epimastigotes. Comp Biochem Physiol B 76: 61-64.
27. Rodríguez-Coura J, de Castro S L 2002. A critical review on Chagas disease chemotherapy. Mem Inst Oswaldo Cruz 97: 3-24.
28. Teixeira AR, Clixto MA, Teixeira ML 1994. Chagas' disease: carcinogenic activity of the antitrypanocidal nitroarenes in mice. Mutation Res 305: 189-196.
29. Tsuhako MH, Alves MJ, Colli W, Filardi LS, Brener Z, Augusto O 1991. Comparative studies of drug resistant and susceptible strains of Trypanosoma cruzi. Comp Biochem Physiol C 99: 317-321.
30. Urbina JA, Payares G, Contreras LM, Liendo A, Sanoja C, Molina J, Piras M, Piras R, Perez N, Wincker P, Loebenberg D 1998. Antiproliferative effects and mechanism of action of SCH 56592 against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies. Antimicrob Agents Chemother 42: 1771-1777.
31. Verlinde CL, Hannaert V, Blonski C, Willson M, Perie JJ, Fothergill-Gilmore LA, Opperdoes FR, Gelb MH, Hol WG, Michels PA 2001. Glycolysis as a target for the design if new anti-trypanosome drugs. Drug Resist Updat 4: 50-65.
32. Wang CC 1995. Molecular mechanism and therapeutic approaches to the treatment of African trypanosomiasis. Ann Rev Pharmacol Toxicol 35: 93-127.
33. Wong C, Rodríguez-Páez L, Nogueda B, Pérez A, Baeza I 1997. Selective inhibition of sperm-specific lactate dehydrogenase isozyme-C4 by N-isopropyl oxamate. Biochim Biophys Acta 1343: 16-22.
34. WHO-World Health Organization. 2002. Control of Chagas disease. WHO Expert Committee. WHO Tech Rep Ser 905: 1-109.
35. Yoshida A 1969. L-malate dehydrogenase. Meth Enzymol 13: 141-145.